Catalyst advances women’s health in new LinkedIn article
On Tuesday, Catalyst's Taryn Serman and Nancy Myers, together with [...]
The Catalyst Team shows support on Rare Disease Day
Being rare is often a blessing: a rare gem stands [...]
Cell & Gene Therapy is making swift progress, and Catalyst is keeping pace.
Scientific innovation in Cell & Gene Therapy (C>) is advancing [...]
The launch of a patient-focused nonprofit: Catalyst Healthcare Consulting lends a hand
Two integral parts of Catalyst’s corporate mission are to 1) [...]
FDA Office of the Ombudsman: Focusing on Communication and Ensuring All Voices Are Heard
During an interview with the Alliance for a Stronger FDA [...]
Califf: FDA will be a ‘more activist’ agency
Regulatory Focus - Aug. 24, 2023 Note: This article describes an [...]
Telework helps FDA compete for scientists. What if it’s no longer an option?
STAT+ May 11, 2023 Catalyst CEO and Founder Nancy Bradish [...]
HHS Floats Trio of Drug Pricing Models, Some More Ambitious Than Others
AISHealth.com - February 23, 2023 Jeff Myers, Catalyst’s Senior [...]
Rare Disease Week: Marking the 40th anniversary of the Orphan Drug Act
By Anne McNickle, VP - Research & Communications, Catalyst Can [...]
CMS sends roses to Sickle Cell Patients; but will the rest of Cell and Gene Therapy get the thorns?
By Jeff Myers, Senior Vice President, Reimbursement Strategy and Market Access, [...]